Български
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

pyrazine/възпаление

Линкът е запазен в клипборда
СтатииКлинични изследванияПатенти
Страница 1 от 63 резултата

Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF THE INVENTION The present invention relates to a class of fused pyrazine compounds capable of binding to the active site of a serine/threonine kinase, the expression of which is involved in the pathway resulting in the degradation of extra-cellular matrix (ECM), joint degeneration and

Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF THE INVENTION The present invention relates to a class of fused pyrazine compounds capable of binding to the active site of a serine/threonine kinase, the expression of which is involved in the pathway resulting in the degradation of extra-cellular matrix (ECM), joint degeneration and

Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF THE INVENTION The present invention relates to a class of fused pyrazine compounds capable of binding to the active site of a serine/threonine kinase, the expression of which is involved in the pathway resulting in the degradation of extra-cellular matrix (ECM), joint degeneration and

Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF THE INVENTION The present invention relates to a class of fused pyrazine compounds capable of binding to the active site of a serine/threonine kinase, the expression of which is involved in the pathway resulting in the degradation of extra-cellular matrix (ECM), joint degeneration and

Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF THE INVENTION This invention relates to biologically active chemical compounds, namely benzoimidazolyl-pyrazine derivatives and structurally related compounds that are used for immunosuppression or to treat or prevent inflammatory conditions, allergic disorders and immune

Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT Not applicable. THE NAMES OF THE PARTIES TO A JOINT RESEARCH AGREEMENT Not applicable. INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC Not applicable. BACKGROUND OF THE INVENTION (1) Field of the Invention This

Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF THE INVENTION This invention relates to biologically active chemical compounds, namely benzoimidazolyl-pyrazine derivatives and structurally related compounds that are used for immunosuppression or to treat or prevent inflammatory conditions, allergic disorders and immune

2-amido pyrazines for inflammation and immune related uses

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF THE INVENTION This invention relates to biologically active chemical compounds, namely pyrazinyl, pyrimidinyl and pyridazinyl derivatives that may be used for immunosuppression or to treat or prevent inflammatory conditions, allergic disorders and immune disorders. BACKGROUND OF THE

Substituted imidazo[1,2-a]pyrazines as TNF activity modulators

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
CROSS-REFERENCE TO RELATED APPLICATIONS This application is a US national phase of International Application No. PCT/EP2013/064332 filed on Jul. 5, 2013, which claims priority to Great Britain Patent Application No. 1212513.4 filed on Jul. 13, 2012. STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH

Pyrrolo[2,3-B]pyrazines as SYK inhibitors

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Protein kinases constitute one of the largest families of human enzymes and regulate many different signaling processes by adding phosphate groups to proteins; particularly tyrosine kinases phosphorylate proteins on the alcohol moiety of tyrosine residues. The tyrosine kinase family includes members

Pyrazine compounds and uses as PI3K inhibitors

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF THE INVENTION This present invention is related to the use of pyrazine derivatives of Formula (I) for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, allergy, asthma,

Pyrazine derivatives and use as PI3K inhibitors

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF THE INVENTION This present invention is related to the use of pyrazine derivatives of Formula (I) for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, allergy, is

Fused tricyclic imidazo pyrazines as modulators of TNF activity

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
This application is a U.S. national phase application under 35 USC 371 of International Patent Application no. PCT/EP2016/062898, filed Jun. 7, 2016, which claims the benefit of Great Britain Application no. 1509888.2, filed Jun. 8, 2015. The present invention relates to a class of fused imidazole

8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds as Lck inhibitors and uses thereof

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
BACKGROUND OF THE INVENTION Non-receptor tyrosine kinases are intracellular enzymes which, in the presence of ATP phosphorylate proteins at tyrosine residues. These enzymes are key regulators of cellular signal transduction, leading to the activation, proliferation and differentiation of cells. The

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
2. BACKGROUND Provided herein are certain heteroaryl compounds, compositions comprising an effective amount of one or more such compounds and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by
Присъединете се към нашата
страница във facebook

Най-пълната база данни за лечебни билки, подкрепена от науката

  • Работи на 55 езика
  • Билкови лекове, подкрепени от науката
  • Разпознаване на билки по изображение
  • Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
  • Прочетете научни публикации, свързани с вашето търсене
  • Търсете лечебни билки по техните ефекти
  • Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите

Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания

Google Play badgeApp Store badge